India is in the grips of a health and humanitarian catastrophe, in stark contrast to Prime Minister Narendra Modi’s declaration of readiness to fight the pandemic.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19
Affichage de 2721 à 2740 de 7938 articles
The British royal family has got more in common with the average family business than you might first imagine.
Nathalie MacDermott was a regular on BBC News, Sky New and ITV. Then COVID broke out at her hospital.
The process will take months, if it’s even approved. But just the threat of waiving intellectual property rights could spur faster action.
The Indian government has been keeping an eye out for India’s vaccine producers by not approving any other vaccines, and by letting them charge what they want. It’s the people who are suffering.
There could still be another challenge on constitutional grounds, but there may not be time before the ban ends anyway.
Although Australians are generally supportive of closed borders, they are split on whether the pandemic has been a boon for national unity and social cohesion.
Many people are unsure if their condition qualifies as an underlying medical condition. They may not realise they’re already eligible for the COVID vaccine.
The survival of the human body is a fine balancing act between cell growth and cell death. Understanding our cells’ complex “licence to die” could give us new ways to combat disease.
Eye contact is essential for building and developing trust. But after more than a year of working and socializing online, our ability to make and maintain eye contact has been diminished.
It is important to remember in this time of crisis that the need for social connection is vital.
Large Canadian cities, usually major tourist destinations, have have experienced drastic declines in tourists and tourism spending while some regional hotspots have been overwhelmed with visitors.
The US has backed a proposal to waive intellectual property relating to COVID measures – but global efforts need to go beyond vaccine patents.
Various strategies are being pursued to boost worldwide vaccine coverage.
Increased demand and falling supplies in India risk leaving many countries empty handed.
The dreadful statistics coming out of India are not just numbers – they relate to people and to suffering.
The change in the US position signals how clearly the success of every country in fighting the pandemic depends on vaccinating the whole world.
The need to transfer 2,500 COVID-19 patients around Ontario, and bring in extra doctors from other provinces, exposes two fallacies about Canada’s health-care system.
It’s not clear whether the TRIPS agreement is what’s getting in the way of vaccine supply, and waiving intellectual property rights may stifle future innovation.
The Indian government spends just US$38 per person on healthcare each year.
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Senior Research Fellow in Global Health, University of Southampton
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of East Anglia
-
Associate professor, UNSW Sydney
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of Virginia
-
Professor of Public Health, University of Sheffield
